Navigation Links
Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
Date:12/3/2007

s in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease and the potential of microRNAs in the diagnosis and treatment of disease constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover and develop novel diagnostics and therapeutic products, which is unproven and may never lead to marketable products; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its product candidates, all of which are in early stages of development; Rosetta's ability to obtain regulatory approval for products; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2006 as filed with the Securities and Exchange Commis
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
3. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
4. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
5. NeoGenomics Announces Results for the 3rd Quarter 2007
6. Kenyan malaria success strengthens call for free insecticide-treated nets for all
7. International study strengthens case for daily calcium pill
8. Wachovia Strengthens Its Healthcare Industry Receivables and Cash Management Capabilities
9. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
10. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
11. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... TheraBreath is proud to announce a new ... also help with overall health. , Many health experts ... ward off bad bacteria that can cause unwanted infections. While ... own, most will need the help of a probiotic to ... levels. , Packed with the S. salivarius M18 & K12 ...
(Date:3/4/2015)... 2015 Theme and plugin developers from ... for Final Cut Pro X entitled ProFont NoteBook , “ProFont ... any FCPX editors project.” Said Christiana Austin, CEO of Pixel ... add animated font to their FCPX media.” , With ProFont ... within Final Cut Pro X. ProFont Notebook offers users up ...
(Date:3/4/2015)... City View producers are pleased ... vicinity. The city of 90 neighborhoods, each with its own ... for everyone. With many outdoor parks, music and fine ... a metropolitan area everyone should visit once in their lifetime. ... bridges. The stunning cable program will be broadcast on PCNC ...
(Date:3/3/2015)... MA (PRWEB) March 04, 2015 ... educational facilities design and construction event for New ... Boston Massachusetts announced key building envelope related workshops. ... , Workshops include: , Curtain Walls ... in many health care and laboratory facilities are ...
(Date:3/3/2015)... New York (PRWEB) March 03, 2015 ... tactics used to market the atypical antipsychotic medication ... U.S. According to court documents, the South Carolina ... finding that Johnson & Johnson’s Janssen Pharmaceuticals unit ... serious risks. However, while the Court’s February 25th ...
Breaking Medicine News(10 mins):Health News:TheraBreath introduces a new line of probiotic lozenges that strengthen the body’s ability to fight germs 2Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2Health News:City View Television Show Will Air in Pittsburgh, PA 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... new ... nationwide survey shows, JACKSONVILLE, Fla., Oct. 29 ... on November 4 and see fewer hours of,daylight, findings from a ... may not be seeing while,driving in the dark. Of further concern, ...
... WuXi PharmaTech (NYSE:,WX), China,s premier provider of pharmaceutical ... the company,s Chairman and Chief Executive,Officer received the ... China,2007 Award. This prestigious award was presented to ... 26 in the China World Hotel, Beijing, China. ...
... blood pressure and are at greater risk of hypertension ... quality and exhibit a smaller nighttime decrease in blood ... , This ethnic difference in blood pressure dipping may ... of hypertension, says Dr. Joel Hughes, Kent State assistant ...
... Digital Pen Technology Allows Hospitals, Medical ... PHILADELPHIA, Oct. 29 Today at the ... the,Docuscan Patient Registration system, an innovative solution for ... the chance of data entry errors. With ...
... America how they ,Think About Their Drink, ST. LOUIS, Oct. 29 , ... the Think About Your Drink ... entered the photo contest by submitting a ... part of a nationwide education campaign, ...
... Another disease can be added to the list ... that smoking increases the risk of developing psoriasis, ... risk decreases only slowly after quitting. Investigators from ... the Harvard School of Public Health, all in ...
Cached Medicine News:Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 2Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 3Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 4Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 2Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 3Health News:Pearson Introduces 'Smart' Technology for Collecting Patient Registration Information 2Health News:Pearson Introduces 'Smart' Technology for Collecting Patient Registration Information 3Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 2Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 3Health News:New study shows smoking increases risk of psoriasis 2
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, ... stem cell-derived islet replacement therapy for the treatment of ... Dr. Eugene Brandon , Director of Strategic Relations ... annual summit showcases the latest in type 1 diabetes ... presentation are as follows: , , , ...
(Date:3/3/2015)... SHANGHAI , March 3, 2015 ... 24 - 26 June 2015, SNIEC, Shanghai, China ... with the 10th P-MEC China, will be held at Shanghai ... CPhI & P-MEC China originated from CPhI Worldwide and was ... become an important bridge between Chinese pharmaceutical companies and global ...
(Date:3/3/2015)... - ChipCare Corporation, a University of Toronto start-up company ... other infectious and non-communicable diseases has closed a ... first-generation product to market while further developing the ... http://photos.prnewswire.com/prnh/20150303/179107 ) Insufficient access ... affordable diagnostic tests makes it difficult to provide ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 215th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3
... recommended for evaluating vitreoretinal relationships ... in the management of dislocated ... lens for small pupil fundus ... It provides a slightly wider ...
... new MagPlus Iridectomy Lens enhances iridectomy ... viewing area (than conventional iridectomy lens ... The bulb on this lens has ... lens) to 11.7mm. The MagPlus comes ...
... advanced fundus laser lens design with Volk ... magnification viewing and treatment of the optic ... aspheric optics provide improved performance over existing ... comes standard with LaserWindow® for optimal laser ...
... with 10mm diameter contact surface is ideal ... prematurety (ROP) and other infant conditions. It ... in the diagnosis and treatment of the ... with narrow palpebral fissures. Developed with Hideyuki ...
Medicine Products: